Navigation Links
PharmaNet Development Group Experts to Share Insights at the 9th Annual Partnerships in Clinical Trials Conference in Vienna
Date:11/1/2010

PRINCETON, N.J., Nov. 1, 2010 /PRNewswire/ -- PharmaNet Development Group, Inc., a leading provider of clinical development services to pharmaceutical, biotechnology, generic drug and medical device companies, today announced its experts will share their insights on key industry topics during the 9th Annual Partnerships in Clinical Trials Conference taking place from 16-19 November at Reed Messe in Vienna, Austria.  

At the conference, members of PharmaNet's management team will discuss the opportunities and challenges currently facing the CRO industry, including the impact of the economic environment on drug development and the need for innovative collaboration in post-marketing studies and biosimilar development.  

Wednesday 17 November 2010 Dalvir Gill, PhD, President, Late Stage Development, will give a keynote presentation, "Surviving Difficult Times: How Much Has the Recession Really Affected Clinical Outsourcing and How Does the Industry Need to Change?"

Jeff Trotter, Executive Vice President, Phase IV Development, will present "Successful Approaches to Partnering in Post-Marketing Studies."

Thursday 18 November 2010Dr. Pablo Fernandez, LMS, FFPM, Senior Vice President, Medical Affairs, will present "Partnering to Overcome the Challenges of Biosimilar Development."

Conference attendees can learn more about PharmaNet's capabilities by visiting booth 129 in the exhibition hall where an international team of representatives will be available to discuss PharmaNet's expertise in helping clients reach their goal of delivering safe and effective therapeutics to patients.

About PharmaNet Development Group, Inc.PharmaNet Development Group, a recognized leader of global drug development services to the pharmaceutical, biotechnology, generic drug, and medical device industries, provides comprehensive capabilities in Phase I-IV clinical development, bioanalytical and bioequivalence services, regulatory, staffing, and therapeutic solutions. For the applied knowledge and intelligent solutions needed to accelerate drug development programs of all sizes around the world, PharmaNet works for you. For more information, please visit www.PharmaNet.com. Contact: Anne-Marie HessPhone:   (609) 951-6842E-mail:   ahess@pharmanet.com
'/>"/>

SOURCE PharmaNet Development Group, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. PharmaNet Development Group Appoints Anthony Maida, Vice President, Clinical Research
2. Stephen Kasay Joins PharmaNet Development Group as Chief Information Officer
3. SEC Closes Investigation of PharmaNet Development Group and Recommends No Action
4. Christopher Brennan Joins PharmaNet Development Group as General Counsel
5. PharmaNet Development Group Provides Financial Update and Announces Geographic Expansion
6. PharmaNet Development Group Clinical Research Experts to Present at Global Professional Meetings in June
7. PharmaNet Development Group Gives Notice of Anticipated Fundamental Change and Merger to Holders of Its Convertible Notes
8. PharmaNet Development Group, Inc. Expands Latin America Operations with Opening of Brazil Office
9. An Affiliate of JLL Partners, Inc. Commences Cash Tender Offer to Acquire PharmaNet Development Group, Inc. at $5.00 per Share
10. PharmaNet Development Group Agrees to be Acquired by JLL Partners
11. Thrombosis Experts Present Update on Important New Developments in Anticoagulation Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 23, 2016   Boston Biomedical , an ... designed to target cancer stemness pathways, announced that ... Orphan Drug Designation from the U.S. Food and ... cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin is ... inhibit cancer stemness pathways by targeting STAT3, and ...
(Date:6/23/2016)... 2016 Houston Methodist Willowbrook Hospital has ... Association to serve as their official health care ... Willowbrook will provide sponsorship support, athletic training services, ... coaches, volunteers, athletes and families. "We ... Association and to bring Houston Methodist quality services ...
(Date:6/23/2016)... -- The Biodesign Challenge (BDC), a university competition that asks ... systems and biotechnology, announced its winning teams at the ... York City . The teams, chosen ... MoMA,s Celeste Bartos Theater during the daylong summit. Keynote ... of architecture and design, and Suzanne Lee , ...
(Date:6/23/2016)... ... 23, 2016 , ... STACS DNA Inc., the sample tracking software company, today ... Laboratory, has joined STACS DNA as a Field Application Specialist. , “I am ... and COO of STACS DNA. “In further expanding our capacity as a scientific integrator, ...
Breaking Biology Technology:
(Date:5/12/2016)... WearablesResearch.com , a brand of Troubadour Research & ... Q1 wave of its quarterly wearables survey. A particular ... a program where they would receive discounts for sharing ... "We were surprised to see that so many ... CEO of Troubadour Research, "primarily because there are segments ...
(Date:4/28/2016)... 28, 2016 First quarter 2016:   ... compared with the first quarter of 2015 The gross ... M (loss: 18.8) and the operating margin was 40% (-13) ... Cash flow from operations was SEK 249.9 M (21.2) , ... is unchanged, SEK 7,000-8,500 M. The operating margin for ...
(Date:4/15/2016)... CHICAGO , April 15, 2016  A ... companies make more accurate underwriting decisions in a ... offering timely, competitively priced and high-value life insurance ... health screenings. With Force Diagnostics, rapid ... and lifestyle data readings (blood pressure, weight, pulse, ...
Breaking Biology News(10 mins):